Sramana Mitra: If you get carried away and raise huge amounts of money, you better have a strategy of doing something that is going to get you to the right exit because all these investors also need exits and you need exits. This is a very complex set of strategic moves that you’re going to
Sramana Mitra: If you look at all the things that they’ve been doing and all the product roadmap announcements that they’ve made, they’re going into clinical trials in a big way. That’s why I asked you the question. Historically, they have come out of CRM but clinical research organizations and clinical trials has been one
Harald Nieder, Partner at Redalpine Venture Partners, an European firm primarily focused on Germany and Switzerland.
Entrepreneurs are invited to the 437th FREE online 1Mby1M mentoring roundtable on Thursday, March 28, 2019, at 8 a.m. PDT/11 a.m. EDT/4 p.m. CET/8:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea. You’ll receive straightforward feedback, advice on next steps, and answers to any of your questions. Others
Sramana Mitra: We have a little company within the 1Mby1M program called CleaningUp. Their discovery is that, as you said, a huge percentage of the workflow of drug development is still on paper and not digital. Especially when trials are held in international locations, people fill out papers. They’re trying to transform that process into
Sramana Mitra: In the last 30 days, we’ve done story after story analyzing what’s happening on the acquisition side of B2B SaaS. I think one of the things that’s very attractive about Arka is that you’re not chasing unicorns and I’ll let you elaborate on that. Yash Hemaraj: You’re right on the point that a
Arihant Patni is Managing Director at Ideaspring Capital, a fund focused on enterprise companies born in India and selling to the global market.
Sramana Mitra: In 1Mby1M, we have a rolling admission. Anyone can join at any time. There’s no three-month program. There’s no concept of graduation. We’re building companies. What would you graduate from? We don’t believe in graduation from an accelerator really. I think these are important points, important differentiators, and important markers to pay attention